Rob Perez Joins Flex Pharma’s Board of Directors
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Flex Pharma (FLKS) Appoints New COO
September 9, 2015 10:18 AM EDTFlex Pharma (NASDAQ: FLKS) announced the appointment of Kathie Lindemann as its Chief Operating Officer, reporting to Christoph Westphal M.D., Ph.D., Flex Pharmas President, CEO and Chair.
Prior to joining Flex Pharma, Ms. Lindemann served as Chief Operating Officer at DAVIDs TEA Inc (NYSE: DTEA). Ms.... More
Flex Pharma (FLKS) Adds Former Cubist Pharma CEO Perez as Director
September 8, 2015 9:48 AM EDTFlex Pharma (NASDAQ: FLKS) announced that Robert J. Perez, former Chief Executive Officer of Cubist Pharmaceuticals, Inc., has joined its Board of Directors.
Mr. Perez joined Cubist in 2003, as Senior Vice President, Sales and Marketing and led the launch of Cubicin® (daptomycin for injection). He served as Executive Vice President and Chief Operating Officer (COO) for the company from 2007 to 2012 and President and COO from 2012 to 2014. Prior to joining Cubist, he served as Vice President of Biogen, Inc.s CNS Business Unit from 2001 to 2003, where he was responsible for commercial leadership of... More
